Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Psychosis Clinical Trials

A listing of Psychosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1076) clinical trials

A Randomized, Open-label, Multiple-dose, Parallel Design, Comparative Bioequivalence Study of Paliperidone Palmitate Extended-Release Injectable Suspension (156 mg/1.0 mL) Versus Invega Sustenna® (paliperidone palmitate) Extended-Release Injectable Suspension (156mg/1.0 mL) in Schizophrenia Patients Already Stabilized on Paliperidone Palmitate

Phase N/A

INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, FIXED-DOSE STUDY OF Lu AF35700 IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA

Phase

The purpose of this study is to test the safety of GW8556553 (the study drug) and how well it works at different doses. We are doing this study in patients with depression (Major Depressive Disorder) to find out: 1. What are the effects of the drug, good or bad? 2. ...

Phase

The objective of this study is to assess the safety and tolerability of the study drug given orally twice daily for 28 days. The study will also assess the effects of study drug on oral and cerebrospinal fluid biomarkers. The study evaluations include 2 detailed dental examinations and 2 lumbar ...

Phase

If you or someone you love suffers from Mild Cognitive Impairment due to Alzheimer's Disease, or mild Alzheimer's Disease, you may be eligible to participate in a research study.

Phase

XanADu Study Worried about Your Memory? Research has shown that having high levels of cortisol over time is associated with the development of Alzheimer’s disease. Xanamem is designed to block the excess production of cortisol – the stress hormone, in the brain. XanADu is a clinical trial of a drug ...

Phase N/A

The purpose of this study is to determine the safety and efficacy of TRx0237 8 mg/day in the treatment of subjects with mild Alzheimer's Disease compared to placebo.

Phase

This is a Phase II, randomised, multi-centre, double-blind, placebo-controlled proof-of-concept study to assess the safety, tolerability and efficacy of oral Xanamem™ once daily in adult subjects with mild dementia due to AD.

Phase

The rrAD study is testing several strategies that may reduce the risk of Alzheimer’s disease in individuals at risk for the disease when compared to usual care. These strategies include: Aerobic exercise Intensive medical management of blood pressure and cholesterol The combination of these two approaches

Phase